Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes
Primary Purpose
Type 2 Diabetes Mellitus, Acute Coronary Syndrome
Status
Terminated
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
telephone contact
Sponsored by
About this trial
This is an interventional supportive care trial for Type 2 Diabetes Mellitus focused on measuring drug compliance, lifestyle modification
Eligibility Criteria
Inclusion Criteria:
- Patients admitted to the 5 HA hospitals with principle diagnosis of CHD, age 45 years for male and 55 for female
- Presence of diabetes according to the 1998 WHO criteria and no history of unprovoked ketosis and not requiring continuous insulin treatment within 1 year of diagnosis
Exclusion Criteria:
- Patients with terminal malignancy or other life-threatening diseases with less than 3-month expected survival
- Telephone contact not available
- Patients with a mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
- Patients who speak non-Cantonese dialect or different language or have conditions that prevent effective communications e.g. patients who are deaf and mute
- Patients who live in nursing home with supervised treatment
- Patients who have participated in another intervention study during the last 1 month and who are enrolled in any intervention studies.
Sites / Locations
- 5 public hospitals in Hong Kong
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
1
2
Arm Description
Lifestyle and compliance counseling via telephone contact with structured set of questions and reinforcements provided
Control arm with usual care as per local hospital practice
Outcomes
Primary Outcome Measures
Composite endpoint of death and/or CVD related hospitalisations (acute myocardial infarction, revascularisation procedures, heart failure or unstable angina or arrhythmia requiring hospital admissions, lower extremity amputation and stroke) by 24 months.
Secondary Outcome Measures
Cardiovascular endpoints
Number of hospital admissions, total number of days of hospitalization
Full Information
NCT ID
NCT00816010
First Posted
December 30, 2008
Last Updated
February 20, 2012
Sponsor
Chinese University of Hong Kong
Collaborators
Hospital Authority, Hong Kong
1. Study Identification
Unique Protocol Identification Number
NCT00816010
Brief Title
Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes
Official Title
A Multicentre, Randomised Study to Examine the Effects of Telephone Intervention in Patients With Coronary Heart Disease and Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
February 2012
Overall Recruitment Status
Terminated
Why Stopped
Due to lack of manpower at the various study sites
Study Start Date
July 2008 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
November 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese University of Hong Kong
Collaborators
Hospital Authority, Hong Kong
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hypothesis To investigate whether telephone counselling by nurse educator between clinic visits with particular emphasis on adherence to medications and lifestyle modification in patients with coronary heart disease and diabetes will reduce mortality and hospitalisation rates due to cardiovascular events compared to usual clinic-based care.
Detailed Description
Study-design A 2-year multicentre, randomised controlled open study involving 5 HA hospitals in Hong Kong.
Subjects and method One thousand two hundred and sixteen patients admitted to hospital with principle diagnosis of coronary heart disease and known or newly confirmed diabetes on oral glucose tolerance test will be enrolled. Patients in the intervention arm (n=608) will receive telephone intervention between clinic visits by diabetes nurse educator using structured counselling tools with particular emphasis on adherence to lifestyle modification and medications as well as self-monitoring of blood glucose, blood pressure and body weight. Patients in control group (n=608) will not receive telephone intervention. Both groups will be followed up by their usual medical teams in their hospitals upon discharge.
Clinical endpoints Primary endpoint is the composite of death and/or cardiovascular related hospitalisations. Secondary endpoints include hospitalisations due to cardiovascular events, number of hospital admissions, total number of days of hospital stay and attendance at the Accident and Emergency Department.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus, Acute Coronary Syndrome
Keywords
drug compliance, lifestyle modification
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
137 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Lifestyle and compliance counseling via telephone contact with structured set of questions and reinforcements provided
Arm Title
2
Arm Type
No Intervention
Arm Description
Control arm with usual care as per local hospital practice
Intervention Type
Behavioral
Intervention Name(s)
telephone contact
Intervention Description
for lifestyle and compliance counseling
Primary Outcome Measure Information:
Title
Composite endpoint of death and/or CVD related hospitalisations (acute myocardial infarction, revascularisation procedures, heart failure or unstable angina or arrhythmia requiring hospital admissions, lower extremity amputation and stroke) by 24 months.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Cardiovascular endpoints
Time Frame
24 months
Title
Number of hospital admissions, total number of days of hospitalization
Time Frame
24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients admitted to the 5 HA hospitals with principle diagnosis of CHD, age 45 years for male and 55 for female
Presence of diabetes according to the 1998 WHO criteria and no history of unprovoked ketosis and not requiring continuous insulin treatment within 1 year of diagnosis
Exclusion Criteria:
Patients with terminal malignancy or other life-threatening diseases with less than 3-month expected survival
Telephone contact not available
Patients with a mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
Patients who speak non-Cantonese dialect or different language or have conditions that prevent effective communications e.g. patients who are deaf and mute
Patients who live in nursing home with supervised treatment
Patients who have participated in another intervention study during the last 1 month and who are enrolled in any intervention studies.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wing Yee So, MRCP, FRCP
Organizational Affiliation
Chinese University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
5 public hospitals in Hong Kong
City
Hong Kong
Country
Hong Kong
12. IPD Sharing Statement
Learn more about this trial
Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes
We'll reach out to this number within 24 hrs